Author Login

Correspondence to Author: Antoni De Frances 

Institute of Microbiology, Department of Molecular and Translational Medicine, University of Brescia-Spedali Civili, 25123 Brescia, Italy

Abstract:

An enveloped, negative single-stranded RNA virus that is a member of the genus Morbillivirus, family Paramyxoviridae, and subfamily Orthoparamyxovirinae is the cause of measles, a highly contagious respiratory infection [1].Patients present with a maculopapular exanthema that extends from the face to the extremities following a 10- to 15-day incubation period. The subject is typically contagious for four days prior to the rash’s onset and four days following its disappearance [2]. Infected patients typically recover swiftly and without any negative consequences. However, children under the age of five, pregnant women, and immunocompromised individuals may experience measles infection-related complications. One of the most common side effects is pneumonia, which can be either a direct result of the virus or a secondary infection [3–5].Rarely seen neurologic complications include subacute sclerosing panencephalitis (SSPE), which develops years after the virus infection [9,10], and acute disseminated encephalomyelitis (ADEM), which primarily affects immunocompromised individuals [6–8] and occurs in 1 case per 1000.

Citation:

Dr.Antoni De Frances, The Resurgence Of Measles In Europe: A Significant Development In The Study Of Vaccine-Preventable Illnesses. Advances in Vaccines 2025.